These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8102150)

  • 1. Depot antipsychotics in bipolar affective disorder.
    White E; Cheung P; Silverstone T
    Int Clin Psychopharmacol; 1993; 8(2):119-22. PubMed ID: 8102150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium prophylaxis of bipolar illness. The value of combination treatment.
    Peselow ED; Fieve RR; Difiglia C; Sanfilipo MP
    Br J Psychiatry; 1994 Feb; 164(2):208-14. PubMed ID: 7909713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot antipsychotics in the prophylaxis of bipolar affective disorder.
    Littlejohn R; Leslie F; Cookson J
    Br J Psychiatry; 1994 Dec; 165(6):827-9. PubMed ID: 7881787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness.
    Shukla S; Cook BL; Miller MG
    J Affect Disord; 1985 Nov; 9(3):219-22. PubMed ID: 2867109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depot antipsychotic medications in bipolar disorder: a review of the literature.
    Bond DJ; Pratoomsri W; Yatham LN
    Acta Psychiatr Scand Suppl; 2007; (434):3-16. PubMed ID: 17688458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia in bipolar affective disorder: relationship to lithium therapy.
    Dinan TG; Kohen D
    Br J Psychiatry; 1989 Jul; 155():55-7. PubMed ID: 2575003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder.
    Di Costanzo E; Schifano F
    Acta Psychiatr Scand; 1991 Jun; 83(6):456-9. PubMed ID: 1882698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders.
    Simhandl C; Denk E; Thau K
    J Affect Disord; 1993 Aug; 28(4):221-31. PubMed ID: 8227758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up.
    Post RM; Leverich GS; Rosoff AS; Altshuler LL
    J Clin Psychopharmacol; 1990 Oct; 10(5):318-27. PubMed ID: 2124216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
    J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based study of the comparative effectiveness of second-generation antipsychotics vs older antimanic agents in bipolar disorder.
    Bauer MS; Miller CJ; Li M; Bajor LA; Lee A
    Bipolar Disord; 2016 Sep; 18(6):481-489. PubMed ID: 27650468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
    Gonzalez-Pinto A; Tohen M; Lalaguna B; Pérez-Heredia JL; Fernandez-Corres B; Gutierrez M; Micó JA
    J Clin Psychopharmacol; 2002 Oct; 22(5):450-4. PubMed ID: 12352266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonazepam vs. neuroleptics as adjuncts to lithium maintenance.
    Sachs GS; Weilburg JB; Rosenbaum JF
    Psychopharmacol Bull; 1990; 26(1):137-43. PubMed ID: 1973545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lithium and carbamazepine combination in the treatment of bipolar disorder--a preliminary report.
    Inoue K; Arima S; Tanaka K; Fukui Y; Kato N
    Folia Psychiatr Neurol Jpn; 1981; 35(4):465-75. PubMed ID: 6806160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination.
    Kishimoto A
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):483-93. PubMed ID: 1641493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication adherence and the use of long-acting antipsychotics in bipolar disorder.
    El-Mallakh RS
    J Psychiatr Pract; 2007 Mar; 13(2):79-85. PubMed ID: 17414683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic efficacy of carbamazepine in manic-depressive illness.
    Post RM; Uhde TW; Ballenger JC; Squillace KM
    Am J Psychiatry; 1983 Dec; 140(12):1602-4. PubMed ID: 6139957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.